Chantal Mathieu
KU Leuven, , Belgium
- This delegate is presenting an abstract at this event.
Chantal Mathieu is Professor of Medicine at the University of Leuven, Belgium and Program Director of Biomedical Sciences. She earned her MD at KU Leuven and trained there in internal medicine and endocrinology. Dr Mathieu has authored or co-authored more than 300 articles in peer-reviewed journals and was an Associate editor and Advisor for Diabetologia. She is a member of the Research Council of Flanders and is a member of the European Association for the Study of Diabetes, the American Diabetes Association, IDS and former President of the Flemish Diabetes Association. Dr Mathieu’s basic research interest is in prevention of Type 1 diabetes and non-classical effects of Vitamin D. Clinically, she is Head of Endocrinology at KUL University Hospital Gasthuisberg and is involved in organisation of clinical diabetes care on a national and international level.
Presentations this author is a contributor to:
Glucagon-Like Peptide-1 protects human islets against cytokine-mediated beta-cell dysfunction and death: a proteomic study of the pathways involved. (#170)
6:00 PM
Lut Overbergh
POSTER SESSION 2 / DRINKS
Molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and mouse islets of Langerhans. (#171)
6:00 PM
Lut Overbergh
POSTER SESSION 2 / DRINKS
Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice (#194)
6:00 PM
Tom Van Belle
POSTER SESSION 2 / DRINKS
1,25-dihydroxyvitamin D3 and its Analogue TX527 Promote a Regulatory T Cell Phenotype in T Cells from Type 1 Diabetic Patients (#195)
6:00 PM
Tom Van Belle
POSTER SESSION 2 / DRINKS
IDS 2013*